Paraneoplastic Myeloneuropathies: Clinical, Oncologic, and Serologic Accompaniments.
Shailee ShahRocio Vazquez Do CampoNeeraj KumarAndrew McKeonEoin P FlanaganChristopher KleinSean J PittockDivyanshu DubeyPublished in: Neurology (2020)
Paraneoplastic etiologies should be considered in the evaluation of subacute myeloneuropathies. Recognition of key characteristics of paraneoplastic myeloneuropathy may facilitate early tumor diagnosis and initiation of immunosuppressive treatment.